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Abstract
A substantial number of patients with preterm labor and delivery do not show clinical signs of
infection, however, it is the subclinical form which is the main causative factor and often results in
premature delivery. The hitherto commonly applied methods of inflammation detection are based
either on potentially hazardous amniocentesis or still insufficient inflammation-related protein
measurement in the serum or other biological fluids.
The advent of new "omics" technologies has led to a paradigm-shift in experimental approach which
tends to primarily generate rather than form hypotheses. This has resulted in a surge of wealth of
data composed of sets of individual or clusters of new genes and proteins that can be of potential
importance as new markers of inflammation leading to preterm labor. It is hoped that as a result
of those new methodologies the overall perception of medical research and practice would
gradually change from reductionist to systems approach. Despite several successes of reductionism
in the diagnosis and treatment of preterm labor it seems that system-based methodology would
contribute to a more favorable personalized rather than one-for-all patient assistance. In this
review we present the current knowledge on this new attractive field of medical studies with
emphasis on early detection of infection related with preterm labor.
Introduction
Preterm birth is the ultimate result of several different
pathways that culminate in the initiation of labor before
37 weeks' gestation. The rate of premature births ranges
between 3,5% (Holland) and 34% (India) and is strongly
dependant on mother's socioeconomic status and/or
familial factors [1-3]. Significant disparities in preterm
birth rates exist between racial and ethnic groups accord-
ing to most recent Institute of Medicine report on preterm
birth [4]. It may be due to a number of factors such as:
nutrition, cigarette smoking, substance use or abuse, work
and physical activity, prenatal care or infection, however,
it is most feasible that cultural and sociological factors are
mainly responsible for the increase in preterm birth rates
in the past decade. The trend toward having children later
in life may be contributing because older women are more
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chance of multiple pregnancy. Although there is no proof
that the rate of infection has been recently augmented it
has relatively well-established molecular physiology and
has been widely accepted as most probable cause of pre-
term birth [5].
Infection and premature birth
Infection, (particularly unrecognised/subclinical infection
in utero) is considered an aetiological factor in around
50% of cases. It is more likely to be associated with deliv-
eries that occur before 30 weeks, as shown by histological
examination of the fetal membranes at delivery, and is rel-
atively rare in late preterm deliveries (at 34 to 36 weeks).
It was shown that up to 80% of women who deliver
before 30 weeks gestation have evidence of bacterial infec-
tion in the amniotic fluid (MIAC – microbial invasion of
the amniotic cavity) and/or membranes compared with
only 30% at 37 weeks gestation [6].
Bacterial infection within the uterus can occur within the
choriodecidual space and most commonly affects fetal
membranes. Resulting chorioamnionitis is usually docu-
mented by histological findings or culture. Merely 10% of
cases manifest clinically during pregnancy by typical signs
and symptoms i.e. one temperature elevation of >38°C,
combined with at least two of the following signs: mater-
nal or fetal tachycardia, uterine tenderness greater than
expected, foul-smelling vaginal discharge, and white
blood cell count of >18,000.
The uterus can be infected by different types of microor-
ganisms via number of routes and haematogenous spread
through the placenta, or ascending from vagina are the
most common causes. Among vaginal infections the most
important are: bacterial vaginosis, chlamydial and tri-
chomonas infection as well as aerobic vaginitis [7].
There is accumulating evidence suggesting that it is
chronic rather than acute inflammatory reaction which is
associated with the development of chorioamnionitis
leading to preterm delivery [8]. Organisms frequently cul-
tured following preterm delivery include genital Myco-
plasma species, in particular Ureaplasma urealyticum,
however other microorganisms are also found, such as:
Mycoplasma hominis, Bacteroides and Fusobacterium species,
Streptococcus agalactiae as well as Gardnerella vaginalis.
When such organisms are found in the amniotic fluid of
pregnant women prior to 20 weeks, the pregnancy usually
ends 4 to 8 weeks later. It is also becoming increasingly
evident that infection leading to preterm delivery actually
occurs quite early in pregnancy and remains undetected
for months prior to delivery [9]. It has been shown that U.
urelyticum has been detected in some proportion of amni-
otic fluid samples at 15 to 18 weeks of gestation and
majority of those women delivered around 24 weeks [10].
In another study interleukin-6 levels were high in the
amniotic fluid at 15–20 weeks and spontaneous preterm
delivery ensued as late as 32 to 34 weeks [9].
The release of endotoxins and exotoxins from bacterial
infection leads to remodelling of the extracellular matrix
(ECM) of gestational tissues (decidua, the cervix and the
fetal membranes) which results in cervical ripening, fetal
membrane rupture as well as placental and membrane
separation from maternal tissues [11,12]. A number of
secreted substances including Tumour Necrosis Factor-α
(TNF-α), Interleukin-1α (IL-1α), IL-1β or IL-6 stimulate
prostaglandin synthesis and release of metalloproteases.
The former stimulate uterine contractions while the latter
degrade the chorioamniotic membranes leading to rup-
ture as well as remodel the collagen in the cervix and sof-
ten it [6].
Reductionists versus systems approach in the 
studies on pathogenesis and early detection of 
preterm labor
As mentioned earlier, intraamniotic infection (IAI) is
often chronic and usually asymptomatic until contrac-
tions begin or membranes prematurely rupture. It is there-
fore crucial to identify women at risk at early stages so that
appropriate treatment strategies can be implemented.
Clinical medicine in general has been basically reduction-
ist which can be best exemplified by the focus on a causa-
tive dominant factor. This for ages has resulted in the
natural inclination to isolate the single factor that is most
responsible for the given pathological status [13]. It has
been widely accepted that every disease has its own
unique target which would be most suitable for medical
intervention. Since for infection the most obvious target is
pathogen the methods for detection of subclinical infec-
tion leading to preterm labor have been in most of the
cases concentrated on detecting bacteria or measuring dif-
ferent "source-related" compounds (eg. cytokines) in
amniotic fluid, vaginal secretion or serum. As amniocen-
tesis is not advocated in women who are in labor, alterna-
tive biological fluids, such as cervicovaginal secretions or
serum are preferable as a source for diagnostic procedures.
There are many examples in general medicine, also in
obstetrical diseases including preterm labor, where reduc-
tionism by means of focusing on a single factors and/or
events is tremendously helpful and efficient as a way to
study pathogenesis as well as search of new biomarkers.
It can among others be exemplified by the positive results
on tests of vaginal secretions for bacterial vaginosis
(defined as a decrease in the normally occurring Lactoba-
cillus species and a massive increase in other organisms)Page 2 of 5
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tion and were sufficient to predict preterm delivery [14]. It
is widely accepted that chronic intrauterine infection leads
to degradation of extracellular chorodecidual basement
membrane, causing leakage of fibronectin (a protein of
the placental membranes) into the vagina, which is the
best predictor of chorioamnionitis and subsequent pre-
term delivery [15].
Although most of the studies showed that concentrations
of high levels of many different cytokines, including TNF-
α, IL-1, IL-6 or IL-8 are associated with preterm delivery
[16,17], the results from two recent studies suggest that
immune response is more complex and likely involves an
interplay of different factors. In particular circumstances
chronic immune status may lead to hyporesponsiveness,
as represented by lower concentrations of some types of
cytokines. In one of the studies it was reported that,
among women with vaginal colonization by anaerobic
Gram-negative rods or G. vaginalis at 18–22 weeks gesta-
tion, there exists an imbalance in the IL-1β and IL-1ra
(receptor antagonists) immunological response. An ele-
vated IL-1β concentration and a diminished IL-1ra:IL-1β
ratio identified women at increased risk for spontaneous
preterm delivery [18].
In another study Simhan et al. performed measurement of
IL-1β, Il-6 and IL-8 in cervical fluid from 403 women at 8
to 20 weeks of gestation and found that genital tract
immune hypo-responsiveness, as measured by decreased
rather than increased lower genital tract concentrations of
studied cytokines, is associated with subsequent chorio-
amnionitis [19]. The authors hypothesised that decreased
concentrations of proinflammatory cytokines may repre-
sent diminished ability to appropriately respond to
potential pathogens. It was also suggested that decreased
cytokine concentrations reflect an inherent genetically
regulated hyporesponse, which permits an infection to
become chronic by allowing organisms to ascend into the
uterus without causing a clinically-evident infection [19].
The above described successes of reductionist approach,
which are based on a priori based hypotheses, leave less
room for more contextual information. Novel types of
"omics" methodologies that are based on platforms for
simultaneous measurement of many different factors
seem to effectively supersede hitherto applied one-by-
one-factor reductionist approaches. It seems especially rel-
evant to complex chronic diseases like preterm labor
where the act of reduction (from larger to smaller) may
result in the lose of attention to other primarily unex-
pected causative factors. These are probably more amena-
ble to systems approach methodology which tends to
generate hypotheses as a consequence of inherent techni-
cal structure of the assay [20].
In our recent study we employed a novel proteomic mini-
array assay to quantitate serum levels of different chemok-
ines in laboring and non-laboring gravidas during pre-
term and term delivery (Figure 1). We excluded patients
with clinical signs of infection, and found that among all
of the studied chemokines it is only CCL19 (also previ-
ously known as Macrophage Inflammatory Protein-3β i.e.
MIP-3β) of which levels were significantly lowered in
women with preterm delivery. Taking into consideration
the results from the two above-cited studies [18,19] we
have also assumed that lower concentration of CCL19
might fit into the scenario of diminished immuno-
responsiveness [21].
The proteomic method that was used in our work is actu-
ally just one of the many in the burgeoning field of
genomics and proteomics. Although the results were
obtained with relatively small amount of examined fac-
tors, nine altogether, we were able to pave the way for
future confirmatory studies on the role of hitherto unex-
plored chemokine in the context of parturition. It there-
fore appears more and more evident that the genes,
proteins or peptides that are preferentially expressed and
identified in a disease or pathologic state are well suited
for the development of much more robust, sensitive and
specific diagnostic assays. For example, Gravett et al. [22]
had for the first time used surface-enhanced laser desorp-
tion-ionization/time-of-flight (SELDI-TOF) mass spec-
trometry in order to characterize amniotic fluid peptides
in Rhesus monkeys before and after experimental intra-
amniotic infection (IAI). The resultant peptide profiles
were subsequently verified in a cohort of women with pre-
term delivery. The objective of the study was to discover
novel biomarkers for subclinical or occult IAI. It was
found, that calgranulin B (expressed by macrophages and
by epithelial cells in acutely inflamed tissues) and a
unique restrictive fragment of Insulin-like Growth Factor
Binding Protein 1 (IGFBP-1) – synthesized by both fetal
membranes and maternal decidua, were differentially
expressed in the amniotic fluid and sera during intra-
amniotic infection prior to the appearance of clinical
symptoms. In contrast, elevated IL-6 concentrations have
not been reported in maternal serum in association with
intra-amniotic infection. However, among all of the
detected proteins those had been defensin-1 and
defensin-2 which were subsequently, by the use of similar
proteomic approaches, found to be of major importance
in the inflammatory response to amniotic infection
[23,24]. It was concluded that these diagnostic protein
expression signatures might have application in the early
detection of IAI [25].
With the advent of cDNA array technology, it has also
become possible to examine simultaneously the expres-
sion of hundreds or thousands of genes encoding multi-Page 3 of 5
(page number not for citation purposes)
BMC Pregnancy and Childbirth 2007, 7(Suppl 1):S9 http://www.biomedcentral.com/1471-2393/7/S1/S9ple classes of proteins, and hence to assess global changes
in gene expression in response to a given condition e.g. in
the myometrium in pregnancy and labor or inflammation
leading to preterm labor [26,27]. In one of the first micro-
array studies on preterm delivery, Marvin et al. used
cytokine-specific 384 gene array to compare expression
level of term and preterm gestational membranes (with
and without chorioamnionits) [28]. The study for the first
time presented evidence for differences not only in the
expression of some new inflammation-associated genes,
including Macrophage Inflammatory Protein-1β (MIP-
1β) and Pulmonary and Activation-Regulated Chemokine
(PARC), but also noted a differential expression patterns
of classes of genes, grouped according to function (e.g.
chemokines) [28].
More recently, it was presented that there exists a
decreased expression of proteinase inhibitor 3 (PI3) in the
preterm premature rupture of membranes (pPROM) cases
as shown by cDNA microarrays which contained 9128
sequence-verified elements that represented a total of
8502 unique clones [29]. Although PI3 (a low-molecular
weight serine proteinase inhibitor that is capable of inhib-
iting neutrophil elastase) had not been implicated previ-
ously to play a role in parturition, the authors proposed
that that the production of PI3 in the fetal membranes
protects the tissue from damage that could be caused by
increased activity and availability of neutrophil elastase.
Patients who are not capable of producing adequate
amounts of PI3 may be predisposed to PPROM. This pro-
vides a novel pathway for investigation in the pathobio-
logic condition of preterm birth that was obtained by a
novel genomic approach which out of more than 8000
factors was efficient to point to one, potentially relevant
[29].
Conclusion
Regardless of which omics-based approach was used the
conclusions from the above-cited studies, and our own,
are quite similar and concern great potential utility of
those methods to identify specific biomarkers and diag-
nostic profiles of preterm labor. Although "omics" meth-
odologies require increasingly sophisticated
computational and mathematical tools which are only
beginning to unravel its full potential we believe the sys-
tems assumption that the forest (e.g. preterm labor) can-
not be explained by studying the trees individually (one
by one factor) will become validated [13]. Only by har-
nessing the "HuGe" (human genome) potential of the
methods through creating collaborative networks based
on interdisciplinary teams, as very recently proposed for
the integration of genomics into obstetrics and gynecol-
ogy [30], we can effectively increase our understanding of
the particular aetiologies involved in this one of the most
challenging obstetrical maladies.
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Mini-array, sandwich-type, enzyme-linked immunosorbent assay for chemokine det ctionFigure 1
Mini-array, sandwich-type, enzyme-linked immuno-
sorbent assay for chemokine detection. (A) Rows and 
columns in the image represent wells, of 96-well polystyrene 
plate, in the bottom of which monoclonal antibodies (mAbs) 
were spotted in a 3 × 3 pattern. After detection the plate 
was imaged with cooled charge-coupled device (CCD) cam-
era. (B) Location of anti-chemokine mAb spots in the mini-
array and CCD camera image of a 3 × 3 mini-array within a 
single well. Among nine of the studied chemokines it is 
CCL19 (also previously known as MIP-3β) which was signifi-
cantly decreased in sera of patients with preterm labor (see 
the text for full details).Page 4 of 5
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